27 related articles for article (PubMed ID: 26481022)
1. Targeting adhesion to the vascular niche to improve therapy for acute myeloid leukemia.
Haltalli MLR; Lo Celso C
Nat Commun; 2020 Jul; 11(1):3691. PubMed ID: 32703951
[TBL] [Abstract][Full Text] [Related]
2. SynLethDB: synthetic lethality database toward discovery of selective and sensitive anticancer drug targets.
Guo J; Liu H; Zheng J
Nucleic Acids Res; 2016 Jan; 44(D1):D1011-7. PubMed ID: 26516187
[TBL] [Abstract][Full Text] [Related]
3. The role of HOXB2 and HOXB3 in acute myeloid leukemia.
Lindblad O; Chougule RA; Moharram SA; Kabir NN; Sun J; Kazi JU; Rönnstrand L
Biochem Biophys Res Commun; 2015 Nov; 467(4):742-7. PubMed ID: 26482852
[TBL] [Abstract][Full Text] [Related]
4. Co-activation of AMPK and mTORC1 Induces Cytotoxicity in Acute Myeloid Leukemia.
Sujobert P; Poulain L; Paubelle E; Zylbersztejn F; Grenier A; Lambert M; Townsend EC; Brusq JM; Nicodeme E; Decrooqc J; Nepstad I; Green AS; Mondesir J; Hospital MA; Jacque N; Christodoulou A; Desouza TA; Hermine O; Foretz M; Viollet B; Lacombe C; Mayeux P; Weinstock DM; Moura IC; Bouscary D; Tamburini J
Cell Rep; 2015 Jun; 11(9):1446-57. PubMed ID: 26004183
[TBL] [Abstract][Full Text] [Related]
5. Proteolytic systems and AMP-activated protein kinase are critical targets of acute myeloid leukemia therapeutic approaches.
Fernandes Â; Azevedo MM; Pereira O; Sampaio-Marques B; Paiva A; Correia-Neves M; Castro I; Ludovico P
Oncotarget; 2015 Oct; 6(31):31428-40. PubMed ID: 25537507
[TBL] [Abstract][Full Text] [Related]
6. [Co-activation of AMPK and mTORC1: a therapeutic application of synthetic lethality in acute myeloid leukemia].
Tamburini J; Poulain L; Bouscary D; Sujobert P
Med Sci (Paris); 2015 Oct; 31(10):836-9. PubMed ID: 26481022
[No Abstract] [Full Text] [Related]
7. The Role of AMPK/mTOR Modulators in the Therapy of Acute Myeloid Leukemia.
Visnjic D; Dembitz V; Lalic H
Curr Med Chem; 2019; 26(12):2208-2229. PubMed ID: 29345570
[TBL] [Abstract][Full Text] [Related]
8. [Roles of mTORC1 in acute myeloid leukemia].
Hoshii T; Hirao A
Rinsho Ketsueki; 2015 Apr; 56(4):359-65. PubMed ID: 25971265
[TBL] [Abstract][Full Text] [Related]
9. Role of AMP-activated protein kinase in cancer therapy.
Rehman G; Shehzad A; Khan AL; Hamayun M
Arch Pharm (Weinheim); 2014 Jul; 347(7):457-68. PubMed ID: 24677093
[TBL] [Abstract][Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
